DGX Quest Diagnostics Incorporated Common Stock
À propos de Quest Diagnostics Incorporated Common Stock Présentation de l'entreprise depuis Wikipedia
Quest Diagnostics est une entreprise de diagnostic médical américaine. Son siège social est situé au New Jersey.
Lire la suite
Quest Diagnostics est une entreprise de diagnostic médical américaine. Son siège social est situé au New Jersey.
Histoire
Son histoire remonte à 1967, sous le nom de MetPath. En 1982, MetPath est acquis par Corning, avant que ce dernier scinde Quest Diagnostics en 1996.
En 2011, Quest Diagnostics acquiert pour 657 millions de dollars, Celera, une entreprise de séquençage génétique.
Références
Portail des entreprises Portail du New Jersey
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
DGX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
DGX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
| Date ex-dividende | Montant |
|---|---|
| 8 juillet 2026 | $0,8600 |
| 6 avril 2026 | $0,8600 |
| 13 janvier 2026 | $0,8000 |
| 3 octobre 2025 | $0,8000 |
| 7 juillet 2025 | $0,8000 |
| 7 avril 2025 | $0,8000 |
| 14 janvier 2025 | $0,7500 |
| 4 octobre 2024 | $0,7500 |
| 8 juillet 2024 | $0,7500 |
| 5 avril 2024 | $0,7500 |
| 16 janvier 2024 | $0,7100 |
| 5 octobre 2023 | $0,7100 |
| 10 juillet 2023 | $0,7100 |
| 6 avril 2023 | $0,7100 |
| 17 janvier 2023 | $0,6600 |
| 3 octobre 2022 | $0,6600 |
| 5 juillet 2022 | $0,6600 |
| 5 avril 2022 | $0,6600 |
| 18 janvier 2022 | $0,6200 |
| 4 octobre 2021 | $0,6200 |
DGX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 6 26,1%
- Achat 7 30,4%
- Conserver 10 43,5%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
15 analystes · 2026-08-23Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $3.12 | $2.85 | 0.27% |
| 31 mars 2026 | $2.50 | $2.37 | 0.13% |
| 31 décembre 2025 | $2.42 | $2.38 | 0.04% |
| 30 septembre 2025 | $2.60 | $2.53 | 0.07% |
| 30 juin 2025 | $2.62 | $2.60 | 0.02% |
| 31 mars 2025 | $2.21 | $2.17 | 0.04% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Cost of Revenue | $7.37B | $6.63B | $6.20B | $6.45B | $6.58B | $5.80B | $5.04B | $4.93B | $4.72B | $4.62B | $4.66B | $4.64B | |
| Gross Profit | · | · | · | · | · | $3.63B | $2.69B | $2.60B | $2.68B | $2.90B | $2.84B | $2.80B | |
| SG&A Expense | $1.97B | $1.77B | $1.64B | $1.87B | $1.73B | $1.55B | $1.46B | $1.42B | $1.44B | $1.38B | $1.68B | $1.73B | |
| Operating Expenses | $9.48B | $8.53B | $7.99B | $8.46B | $8.41B | $7.47B | $6.50B | $6.43B | $6.24B | $5.94B | $6.09B | $6.45B | |
| Operating Income | $1.56B | $1.35B | $1.26B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.28B | $1.40B | $983M | |
| Interest Expense | · | · | $163M | $148M | $152M | $166M | $180M | $169M | $153M | $144M | $154M | $167M | |
| Interest Income | $13M | $25M | $11M | $10M | $1M | $3M | $5M | $2M | $2M | $1M | $1M | $3M | |
| Other Non-op | $26M | $30M | $20M | $-55M | $369M | $76M | $20M | $-8M | $16M | $-48M | $-143M | $4M | |
| Pretax Income | $1.32B | $1.18B | $1.13B | $1.24B | $2.60B | $1.88B | $1.08B | $926M | $1.03B | $1.09B | $1.10B | $823M | |
| Income Tax | $314M | $273M | $248M | $264M | $597M | $460M | $247M | $182M | $241M | $429M | $373M | $262M | |
| Net Income | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| EPS (Basic) | $8.87 | $7.78 | $7.59 | $8.10 | $15.85 | $10.62 | $6.36 | $5.39 | $5.63 | $4.58 | $4.92 | $3.83 | |
| EPS (Diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 | |
| Shares (Basic) | 111,000,000 | 111,000,000 | 112,000,000 | 116,000,000 | 125,000,000 | 134,000,000 | 134,000,000 | 136,000,000 | 137,000,000 | 140,000,000 | 144,000,000 | 145,000,000 | |
| Shares (Diluted) | 113,000,000 | 113,000,000 | 113,000,000 | 118,000,000 | 128,000,000 | 136,000,000 | 136,000,000 | 139,000,000 | 140,000,000 | 142,000,000 | 145,000,000 | 145,000,000 | |
| EBITDA | $2.13B | $1.84B | $1.70B | $1.86B | $2.79B | $2.33B | $1.56B | $1.41B | $1.44B | $1.53B | $1.70B | $1.30B |
Bilan 27
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420M | $549M | $686M | $315M | $872M | $1.16B | $1.19B | $135M | $137M | $359M | $133M | $192M | |
| Receivables | $1.41B | $1.30B | $1.21B | $1.20B | $1.44B | $1.52B | $1.06B | $1.01B | $924M | $926M | $901M | $932M | |
| Inventory | $189M | $188M | $190M | $192M | $208M | $223M | $123M | $99M | $95M | $82M | $84M | $110M | |
| Prepaid Expense | $361M | $351M | $286M | $196M | $223M | $157M | $112M | $144M | $150M | $155M | $207M | $186M | |
| Current Assets | $2.38B | $2.39B | $2.37B | $1.90B | $2.74B | $3.06B | $2.49B | $1.39B | $1.31B | $1.53B | $1.50B | $1.60B | |
| PP&E (Net) | $2.20B | $2.11B | $1.82B | $1.77B | $1.71B | $1.63B | $1.45B | $1.29B | $1.15B | $1.03B | $925M | $933M | |
| PP&E (Gross) | $6.18B | $5.77B | $5.23B | $5.10B | $4.79B | $4.62B | $4.23B | $3.97B | $3.67B | $3.43B | $3.23B | $3.13B | |
| Accum. Depreciation | $3.97B | $3.66B | $3.42B | $3.34B | $3.09B | $2.99B | $2.78B | $2.68B | $2.53B | $2.40B | $2.31B | $2.19B | |
| Goodwill | $8.95B | $8.86B | $7.73B | $7.22B | $7.09B | $6.87B | $6.62B | $6.56B | $6.33B | $6.00B | $5.91B | $6.03B | |
| Intangibles | $1.64B | $1.76B | $1.17B | $1.09B | $1.17B | $1.17B | $1.12B | $1.21B | $1.12B | $949M | $984M | $1.07B | |
| Other Non-current Assets | $270M | $255M | $198M | $144M | $163M | $176M | $160M | $119M | $136M | $148M | $174M | $172M | |
| Total Assets | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Accounts Payable | $1.60B | $1.39B | $1.36B | $1.40B | $1.60B | $1.63B | $1.04B | $1.02B | $1.02B | $975M | $1.01B | $1.19B | |
| Accrued Liabilities | $338M | $306M | $287M | $392M | $460M | $356M | $223M | $274M | $246M | $254M | $257M | $277M | |
| Current Liabilities | $2.28B | $2.17B | $1.81B | $1.55B | $1.75B | $1.78B | $1.99B | $1.49B | $1.06B | $981M | $1.17B | $1.71B | |
| Capital Leases | $537M | $535M | $503M | $489M | $494M | $499M | $413M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $264M | $243M | $170M | $191M | $157M | $204M | |
| Other Non-current Liabilities | $957M | $938M | $876M | $812M | $792M | $847M | $711M | $745M | $663M | $654M | $514M | $594M | |
| Long-term Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.74B | |
| Total Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.76B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $9.99B | $9.36B | $8.82B | $8.29B | $7.65B | $9.30B | $8.17B | $7.60B | $7.14B | $6.61B | $6.20B | $5.72B | |
| Treasury Stock | $5.18B | $4.86B | $4.83B | $4.67B | $3.45B | $5.37B | $5.22B | $5.00B | $4.78B | $4.46B | $3.96B | $3.81B | |
| AOCI | $-27M | $-88M | $-14M | $-21M | $-14M | $-21M | $-39M | $-59M | $-48M | $-72M | $-38M | $-27M | |
| Stockholders' Equity | $7.17B | $6.78B | $6.31B | $5.89B | $6.44B | $6.76B | $5.64B | $5.22B | $4.92B | $4.63B | $4.68B | $4.30B | |
| Liabilities + Equity | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 119,000,000 | 133,000,000 | 133,000,000 | 135,000,000 | 135,000,000 | 137,000,000 | 143,000,000 | 144,000,000 |
Flux de trésorerie 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $570M | $493M | $439M | $437M | $408M | $361M | $329M | $309M | $270M | $249M | $304M | $314M | |
| Stock-based Comp | $88M | $88M | $77M | $77M | $79M | $97M | $56M | $61M | $79M | $69M | $52M | $51M | |
| Deferred Tax | $105M | $13M | $-49M | $1M | $-57M | $85M | $15M | $73M | $9M | $37M | $112M | $23M | |
| Amort. of Intangibles | $154M | $127M | $108M | $120M | $103M | $103M | $96M | $90M | $74M | $72M | $81M | $94M | |
| Restructuring | · | · | · | $55M | $13M | $14M | $-3M | $49M | $30M | $11M | $39M | $43M | |
| Other Non-cash | $131M | $-131M | $-49M | $257M | $-192M | $31M | $-15M | $21M | $45M | $69M | $-367M | $-6M | |
| Operating Cash Flow | $1.89B | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.12B | $821M | $944M | |
| CapEx | $527M | $425M | $408M | $404M | $403M | $418M | $400M | $383M | $252M | $293M | $263M | $308M | |
| Investing Cash Flow | $-631M | $-2.55B | $-1.06B | $-543M | $21M | $-772M | $-411M | $-801M | $-830M | $-127M | $-362M | $-1.02B | |
| Stock Repurchased | $450M | $151M | $275M | $1.41B | $2.20B | $325M | $353M | $322M | $465M | $590M | $224M | $132M | |
| Net Stock Activity | $-450M | $-151M | $-275M | $-1.41B | $-2.20B | $-325M | $-353M | $-322M | $-465M | $-590M | $-224M | $-132M | |
| Dividends Paid | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M | |
| Financing Cash Flow | $-1.39B | $1.08B | $160M | $-1.73B | $-2.54B | $-1.27B | $225M | $-401M | $-592M | $-738M | $-518M | $86M | |
| Net Change in Cash | $-129M | $-137M | $371M | $-557M | $-286M | · | · | · | $-222M | $226M | $-59M | $5M | |
| Taxes Paid | $169M | $256M | $317M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.36B | $909M | $864M | $1.31B | $1.83B | $1.59B | $843M | $817M | $923M | $776M | $547M | $630M | |
| Levered FCF | · | · | $737M | $1.20B | $1.71B | $1.46B | $704M | $681M | $806M | $689M | · | · |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 38.5% | 34.8% | 34.6% | 38.8% | 38.6% | 37.9% | 37.6% | |
| Operating Margin | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.1% | 17.0% | 18.7% | 13.2% | |
| Net Margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.0% | 8.6% | 9.5% | 7.5% | |
| Pretax Margin | 11.9% | 11.9% | 12.2% | 12.5% | 24.1% | 20.0% | 13.9% | 12.3% | 13.4% | 14.4% | 14.7% | · | |
| EBITDA Margin | 19.3% | 18.6% | 18.4% | 18.9% | 25.9% | 24.7% | 20.2% | 18.7% | 18.6% | 20.3% | 22.7% | 17.4% | |
| ROA | 6.1% | 5.8% | 6.4% | 7.1% | 14.4% | 10.7% | 7.2% | 6.8% | 7.5% | 6.4% | 7.1% | 5.9% | |
| ROE | 14.2% | 13.3% | 14.0% | 15.3% | 30.2% | 23.1% | 15.8% | 14.5% | 16.2% | 13.9% | 15.8% | 13.5% | |
| ROIC | 9.2% | 8.0% | 8.9% | 11.4% | 17.5% | 13.8% | 9.1% | 9.7% | 10.2% | 9.2% | 11.1% | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 | 1.7 | 1.3 | 0.9 | 1.2 | 1.6 | 1.3 | 0.9 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 | 1.5 | 1.1 | 0.8 | 1.0 | 1.3 | 0.9 | 0.7 | |
| Debt / Equity | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 | |
| Interest Coverage | · | · | 7.7 | 9.6 | 15.7 | 11.9 | 6.8 | 6.5 | 7.6 | 8.9 | · | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
| Inventory Turnover | 39.1 | 35.1 | 32.5 | 32.2 | 30.5 | 33.5 | 45.4 | 50.8 | 53.3 | 55.6 | 48.0 | 46.1 | |
| Receivables Turnover | 8.1 | 7.9 | 7.7 | 7.5 | 7.3 | 7.3 | 7.4 | 7.8 | 8.3 | 8.2 | 8.2 | 8.3 |
Taux de croissance 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 6.7% | -6.4% | -8.4% | 14.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 3.7% | -2.9% | -0.66% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 13.8% | 2.7% | -6.0% | -48.8% | 48.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.2% | -20.9% | -10.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 13.9% | 2.0% | -9.7% | -52.6% | 39.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.6% | -24.1% | -15.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 3.5% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Net Income TTM | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| Market Cap | $19.09B | $16.75B | $15.30B | $17.36B | $20.59B | $15.85B | $14.20B | $11.24B | $13.30B | $12.59B | $10.17B | $9.66B | |
| Enterprise Value | $24.34B | $22.41B | $19.33B | $21.03B | $23.73B | $18.71B | $17.78B | $15.00B | $16.94B | $15.97B | $13.69B | $13.23B | |
| P/E | 19.8 | 19.6 | 18.4 | 19.6 | 11.1 | 11.4 | 17.0 | 15.7 | 17.9 | 20.4 | 14.6 | 17.6 | |
| P/S | 1.7 | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.8 | 1.5 | 1.8 | 1.7 | 1.4 | 1.3 | |
| P/B | 2.7 | 2.5 | 2.4 | 2.9 | 3.2 | 2.3 | 2.5 | 2.2 | 2.7 | 2.7 | 2.2 | 2.2 | |
| P / Cash Flow | 10.1 | 12.6 | 12.0 | 10.1 | 9.2 | 7.9 | 11.4 | 9.4 | 11.3 | 11.8 | 12.6 | 10.3 | |
| P / FCF | 14.0 | 18.4 | 17.7 | 13.2 | 11.3 | 10.0 | 16.8 | 13.8 | 14.4 | 16.2 | 18.6 | 15.3 | |
| EV / EBITDA | 11.4 | 12.2 | 11.4 | 11.3 | 8.5 | 8.0 | 11.4 | 10.6 | 11.8 | 10.5 | 8.0 | 10.2 | |
| EV / FCF | 17.9 | 24.7 | 22.4 | 16.0 | 13.0 | 11.8 | 21.1 | 18.4 | 18.4 | 20.6 | 25.0 | 21.0 | |
| EV / Revenue | 2.2 | 2.3 | 2.1 | 2.1 | 2.2 | 2.0 | 2.3 | 2.0 | 2.3 | 2.2 | 1.8 | 1.8 | |
| Dividend Yield | 1.8% | 2.0% | 2.1% | 1.8% | 1.5% | 1.9% | 2.0% | 2.4% | 1.9% | 1.8% | 2.1% | 1.9% | |
| Earnings Yield | 5.0% | 5.1% | 5.4% | 5.1% | 9.0% | 8.8% | 5.9% | 6.3% | 5.6% | 4.9% | 6.9% | 5.7% | |
| Payout Ratio | 35.6% | 38.0% | 36.8% | 32.2% | 15.5% | 20.8% | 33.3% | 36.1% | 32.0% | 34.6% | 29.9% | 33.6% | |
| Annual Payout | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B | $2.40B | $2.37B | $2.29B | $2.29B | $2.34B | $2.33B | $2.33B | $2.49B | |
| Cost of Revenue | $2.02B | $1.95B | $1.90B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B | $1.59B | $1.59B | $1.55B | $1.54B | $1.55B | $1.56B | $1.57B | $1.62B | |
| SG&A Expense | $529M | $504M | $504M | $501M | $486M | $476M | $466M | $448M | $416M | $440M | $407M | $380M | $416M | $439M | $563M | $464M | |
| Operating Expenses | $2.58B | $2.50B | $2.42B | $2.43B | $2.32B | $2.31B | $2.26B | $2.16B | $2.04B | $2.07B | $2.02B | $1.95B | $1.99B | $2.03B | $2.20B | $2.09B | |
| Operating Income | $459M | $399M | $386M | $386M | $438M | $346M | $361M | $330M | $355M | $300M | $267M | $342M | $348M | $305M | $135M | $392M | |
| Interest Expense | · | · | · | · | · | · | · | · | $47M | $49M | · | $41M | $39M | $37M | · | $37M | |
| Interest Income | $5M | $2M | $3M | $3M | $2M | $5M | $7M | $9M | $3M | $6M | $6M | $1M | $2M | $2M | $4M | $4M | |
| Other Non-op | $16M | $-2M | $8M | $8M | $13M | $-3M | $3M | $15M | $3M | $9M | $10M | $-3M | $6M | $7M | $6M | $-8M | |
| Pretax Income | $412M | $334M | $330M | $328M | $384M | $276M | $299M | $296M | $314M | $266M | $237M | $299M | $317M | $277M | $109M | $351M | |
| Income Tax | $88M | $74M | $81M | $77M | $97M | $59M | $68M | $65M | $74M | $66M | $40M | $68M | $75M | $65M | $-4M | $81M | |
| Net Income | $320M | $252M | $245M | $245M | $282M | $220M | $222M | $226M | $229M | $194M | $192M | $225M | $235M | $202M | $101M | $256M | |
| EPS (Basic) | $2.88 | $2.27 | $2.21 | $2.18 | $2.51 | $1.97 | $1.98 | $2.01 | $2.05 | $1.74 | $1.72 | $1.99 | $2.08 | $1.80 | $0.93 | $2.20 | |
| EPS (Diluted) | $2.84 | $2.24 | $2.18 | $2.16 | $2.47 | $1.94 | $1.95 | $1.99 | $2.03 | $1.72 | $1.70 | $1.96 | $2.05 | $1.78 | $0.92 | $2.17 | |
| Shares (Basic) | 111,000,000 | 110,000,000 | -224,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | -223,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | -224,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | -236,000,000 | 116,000,000 | |
| Shares (Diluted) | 112,000,000 | 112,000,000 | -226,000,000 | 113,000,000 | 113,000,000 | 113,000,000 | -224,000,000 | 113,000,000 | 112,000,000 | 112,000,000 | -228,000,000 | 114,000,000 | 114,000,000 | 113,000,000 | -240,000,000 | 118,000,000 | |
| EBITDA | $605M | $546M | · | $528M | $581M | $486M | · | $455M | $472M | $416M | · | $453M | $460M | $412M | · | $500M |
Bilan 26
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $626M | $393M | $420M | $432M | $319M | $188M | $549M | $764M | $271M | $474M | · | $143M | $126M | $175M | · | $700M | |
| Receivables | $1.67B | $1.59B | $1.41B | $1.46B | $1.42B | $1.40B | $1.30B | $1.38B | $1.32B | $1.32B | · | $1.28B | $1.24B | $1.25B | · | $1.28B | |
| Inventory | $233M | $225M | $189M | $186M | $187M | $189M | $188M | $184M | $182M | $181M | · | $184M | $184M | $190M | · | $183M | |
| Prepaid Expense | $319M | $361M | $361M | $333M | $273M | $294M | $351M | $299M | $245M | $251M | · | $207M | $188M | $195M | · | $171M | |
| Current Assets | $2.84B | $2.57B | $2.38B | $2.41B | $2.20B | $2.08B | $2.39B | $2.62B | $2.02B | $2.23B | · | $1.81B | $1.73B | $1.81B | · | $2.33B | |
| PP&E (Net) | $2.22B | $2.19B | $2.20B | $2.15B | $2.12B | $2.10B | $2.11B | $2.09B | $1.83B | $1.81B | · | $1.83B | $1.81B | $1.79B | · | $1.71B | |
| PP&E (Gross) | · | · | $6.18B | · | · | · | $5.77B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.97B | · | · | · | $3.66B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $9.11B | $9.12B | $8.95B | $8.90B | $8.88B | $8.85B | $8.86B | $8.61B | $7.88B | $7.83B | $7.73B | $7.73B | $7.73B | $7.24B | $7.22B | $7.19B | |
| Intangibles | $1.67B | $1.72B | $1.64B | $1.66B | $1.71B | $1.73B | $1.76B | $1.72B | $1.20B | $1.19B | · | $1.22B | $1.25B | $1.08B | · | $1.11B | |
| Other Non-current Assets | $277M | $256M | $270M | $296M | $271M | $260M | $255M | $272M | $216M | $182M | · | $149M | $152M | $150M | · | $132M | |
| Total Assets | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Accounts Payable | $1.60B | $1.50B | $1.60B | $1.46B | $1.35B | $1.27B | $1.39B | $1.31B | $1.25B | $1.24B | · | $1.16B | $1.20B | $1.20B | · | $1.45B | |
| Accrued Liabilities | · | · | $338M | · | · | · | $306M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $1.79B | $2.18B | $2.28B | $2.13B | $2.02B | $1.44B | $2.17B | $2.09B | $2.01B | $2.30B | · | $1.62B | $1.88B | $1.35B | · | $1.60B | |
| Capital Leases | $561M | $574M | $537M | $534M | $540M | $538M | $535M | $543M | $507M | $489M | · | $505M | $508M | $490M | · | $505M | |
| Other Non-current Liabilities | $1.06B | $1.02B | $957M | $982M | $890M | $917M | $938M | $891M | $811M | $817M | · | $874M | $901M | $809M | · | $787M | |
| Long-term Debt | $5.64B | · | $5.67B | · | · | · | $6.22B | $6.25B | · | · | · | · | · | · | · | · | |
| Total Debt | $5.64B | $503M | · | $504M | $504M | $1M | · | $6.25B | $606M | $906M | · | $304M | $518M | $2M | · | $2M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Retained Earnings | $10.37B | $10.15B | $9.99B | $9.84B | $9.68B | $9.49B | $9.36B | $9.22B | $9.08B | $8.94B | · | $8.71B | $8.57B | $8.41B | · | $8.26B | |
| Treasury Stock | $5.17B | $5.09B | $5.18B | $4.90B | $4.77B | $4.79B | $4.86B | $4.73B | $4.76B | $4.78B | · | $4.57B | $4.59B | $4.61B | · | $4.27B | |
| AOCI | $-62M | $-43M | $-27M | $-40M | $-16M | $-83M | $-88M | $-15M | $-19M | $-16M | · | $-20M | $-16M | $-18M | · | $-31M | |
| Stockholders' Equity | $7.52B | $7.37B | $7.17B | $7.26B | $7.23B | $6.93B | $6.78B | $6.81B | $6.62B | $6.43B | · | $6.42B | $6.25B | $6.05B | · | $6.24B | |
| Liabilities + Equity | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 110,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 114,000,000 |
Flux de trésorerie 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $146M | $147M | $145M | $142M | $143M | $140M | $135M | $125M | $117M | $116M | $109M | $111M | $112M | $107M | $116M | $108M | |
| Stock-based Comp | $23M | $20M | $25M | $20M | $21M | $22M | $27M | $19M | $20M | $22M | $19M | $18M | $16M | $24M | $22M | $18M | |
| Deferred Tax | $-2M | $48M | $-13M | $110M | $1M | $7M | $34M | $15M | $-18M | $-18M | $-10M | $-23M | $-12M | $-4M | $-44M | $65M | |
| Amort. of Intangibles | $38M | $37M | $37M | $39M | $39M | $39M | $37M | $32M | $29M | $29M | $27M | $27M | $28M | $26M | $39M | $27M | |
| Restructuring | · | · | · | $6M | $1M | · | · | $7M | $8M | · | · | $1M | $1M | · | · | · | |
| Other Non-cash | · | $-189M | · | · | · | $-75M | · | · | · | $-160M | · | · | · | $-235M | · | · | |
| Operating Cash Flow | $597M | $278M | $465M | $563M | $544M | $314M | $464M | $356M | $360M | $154M | $527M | $207M | $444M | $94M | $334M | $502M | |
| CapEx | $138M | $114M | $158M | $144M | $108M | $117M | $123M | $106M | $92M | $104M | $72M | $105M | $104M | $127M | $147M | $118M | |
| Investing Cash Flow | $-134M | $-152M | $-191M | $-201M | $-124M | $-115M | $-502M | $-1.63B | $-200M | $-213M | $-114M | $-107M | $-682M | $-158M | $-174M | $-118M | |
| Stock Repurchased | · | · | $300M | $150M | · | · | $151M | · | · | · | $275M | $0 | $0 | $0 | $461M | $374M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $96M | $88M | $90M | $89M | $90M | $84M | $84M | $84M | $84M | $79M | $80M | $80M | $80M | $74M | $75M | $78M | |
| Financing Cash Flow | $-229M | $-152M | $-287M | $-247M | $-293M | $-561M | $-170M | $1.77B | $-363M | $-153M | $130M | $-83M | $189M | $-76M | $-545M | $-474M | |
| Net Change in Cash | $233M | $-27M | $-12M | $113M | $131M | $-361M | $-215M | $493M | $-203M | $-212M | $543M | $17M | $-49M | $-140M | $-385M | $-90M | |
| Free Cash Flow | · | $164M | · | · | · | $197M | · | · | · | $50M | · | · | · | $-33M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $13M | · | · | · | $-61M | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.1% | 13.8% | · | 13.7% | 15.9% | 13.1% | · | 13.3% | 14.8% | 12.7% | · | 14.9% | 14.9% | 13.1% | · | 15.8% | |
| Net Margin | 10.5% | 8.7% | · | 8.7% | 10.2% | 8.3% | · | 9.1% | 9.6% | 8.2% | · | 9.8% | 10.1% | 8.7% | · | 10.3% | |
| Pretax Margin | 13.5% | 11.5% | · | 11.7% | 13.9% | 10.4% | · | 11.9% | 13.1% | 11.2% | · | 13.0% | 13.6% | 11.9% | · | 14.1% | |
| EBITDA Margin | 19.9% | 18.9% | · | 18.8% | 21.0% | 18.3% | · | 18.3% | 19.7% | 17.6% | · | 19.7% | 19.7% | 17.7% | · | 20.1% | |
| ROA | 1.9% | 1.6% | · | 1.5% | 1.9% | 1.5% | · | 1.5% | 1.7% | 1.5% | · | 1.7% | 1.8% | 1.5% | · | 1.9% | |
| ROE | 4.3% | 3.5% | · | 3.5% | 4.1% | 3.3% | · | 3.4% | 3.6% | 3.1% | · | 3.5% | 3.7% | 3.2% | · | 4.0% | |
| ROIC | 2.7% | 4.0% | · | 3.8% | 4.2% | 3.9% | · | 2.0% | 3.8% | 3.1% | · | 3.9% | 3.9% | 3.9% | · | 4.8% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.2 | · | 1.1 | 1.1 | 1.4 | · | 1.3 | 1.0 | 1.0 | · | 1.1 | 0.9 | 1.3 | · | 1.5 | |
| Quick Ratio | 1.3 | 0.9 | · | 0.9 | 0.9 | 1.1 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | 0.7 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.8 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.9 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.7 | · | · | · | · | · | · | 0.8 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 7.6 | 6.1 | · | 8.3 | 8.9 | 8.2 | · | 10.6 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 9.6 | 9.4 | · | 10.1 | 9.9 | 9.7 | · | 9.1 | 8.7 | 8.6 | · | 8.4 | 8.3 | 8.1 | · | 8.3 | |
| Receivables Turnover | 2.0 | 1.9 | · | 2.0 | 2.0 | 1.9 | · | 1.9 | 1.9 | 1.8 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.52B | $11.12B | · | $10.72B | $10.30B | $9.90B | · | $9.55B | $9.40B | $9.33B | · | $9.45B | $9.61B | $9.88B | · | $10.32B | |
| Net Income TTM | $1.10B | $999M | · | $973M | $957M | $869M | · | $874M | $883M | $856M | · | $918M | $927M | $1.05B | · | $1.35B | |
| Market Cap | $23.31B | $21.75B | · | $21.15B | $20.12B | $18.95B | · | $17.39B | $15.19B | $14.78B | · | $13.65B | $15.74B | $15.85B | · | $13.99B | |
| Enterprise Value | $28.33B | $21.86B | · | $21.23B | $20.30B | $18.76B | · | $22.88B | $15.53B | $15.21B | · | $13.81B | $16.13B | $15.67B | · | $13.29B | |
| P/E | 21.8 | 22.2 | · | 22.3 | 21.3 | 22.0 | · | 20.2 | 17.6 | 17.7 | · | 15.3 | 17.7 | 16.0 | · | 11.1 | |
| P/S | 2.0 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.6 | 1.6 | · | 1.4 | 1.6 | 1.6 | · | 1.4 | |
| P/B | 3.1 | 3.0 | · | 2.9 | 2.8 | 2.7 | · | 2.6 | 2.3 | 2.3 | · | 2.1 | 2.5 | 2.6 | · | 2.2 | |
| P / Cash Flow | · | 78.3 | · | · | · | 60.4 | · | · | · | 95.9 | · | · | · | 168.6 | · | · | |
| P / FCF | · | 132.6 | · | · | · | 96.2 | · | · | · | 295.5 | · | · | · | -480.2 | · | · | |
| EV / EBITDA | 46.8 | 40.0 | · | 40.2 | 34.9 | 38.6 | · | 50.3 | 32.9 | 36.6 | · | 30.5 | 35.1 | 38.0 | · | 26.6 | |
| EV / FCF | · | 133.3 | · | · | · | 95.2 | · | · | · | 304.1 | · | · | · | -474.9 | · | · | |
| EV / Revenue | 2.5 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 2.4 | 1.7 | 1.6 | · | 1.5 | 1.7 | 1.6 | · | 1.3 | |
| Earnings Yield | 4.6% | 4.5% | · | 4.5% | 4.7% | 4.5% | · | 5.0% | 5.7% | 5.6% | · | 6.5% | 5.7% | 6.2% | · | 9.0% | |
| Payout Ratio | · | 34.9% | · | · | · | 38.2% | · | · | · | 40.7% | · | · | · | 36.6% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| Marge d'exploitation % | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% |
| Résultat net | $992M | $871M | $854M | $946M | $2.00B |
| BPA dilué | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 |
| Ratio de liquidité | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 |
| Ratio de liquidité réduite | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $1.36B | $909M | $864M | $1.31B | $1.83B |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 1 176 déclarants · $12.9B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 115 (-25 vs T. préc.) | 64 (-17 vs T. préc.) | 415 (+69 vs T. préc.) | 333 (-20 vs T. préc.) | +7.5M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1 533 117 858 | 7 233 394 | 11,93% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 299 474 988 | 6 131 045 | 10,11% | Actions |
| STATE STREET CORP | $1 169 252 484 | 5 516 643 | 9,10% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $584 135 885 | 2 767 754 | 4,54% | Actions |
| EdgePoint Investment Group Inc. | $476 372 038 | 2 247 568 | 3,71% | Actions |
| Grantham, Mayo, Van Otterloo & Co. LLC | $400 206 122 | 1 888 207 | 3,11% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $357 050 202 | 1 684 597 | 2,78% | Actions |
| Davis Selected Advisers | $329 781 509 | 1 555 612 | 2,57% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $311 037 928 | 1 467 506 | 2,42% | Actions |
| NORGES BANK | $298 133 109 | 1 406 620 | 2,32% | Actions |
| FMR LLC | $227 315 614 | 1 072 496 | 1,77% | Actions |
| AMERICAN CENTURY COMPANIES INC | $173 422 135 | 818 220 | 1,35% | Actions |
| M&G PLC | $168 677 800 | 795 650 | 1,31% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $131 756 386 | 621 639 | 1,03% | Actions |
| ALLIANCEBERNSTEIN L.P. | $122 662 706 | 625 894 | 0,95% | Actions |
| AMERIPRISE FINANCIAL INC | $109 652 758 | 517 352 | 0,85% | Actions |
| Woodline Partners LP | $102 974 000 | 485 841 | 0,80% | Actions |
| FIDUCIARY MANAGEMENT INC /WI/ | $102 489 906 | 483 557 | 0,80% | Actions |
| Artemis Investment Management LLP | $99 175 856 | 467 921 | 0,77% | Actions |
| CRAWFORD INVESTMENT COUNSEL INC | $97 514 204 | 460 081 | 0,76% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $91 995 201 | 434 042 | 0,72% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $90 834 224 | 428 564 | 0,71% | Actions |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $86 608 697 | 407 302 | 0,67% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $83 772 178 | 395 245 | 0,65% | Actions |
| M.D. Sass, LLC | $76 397 960 | 360 453 | 0,59% | Actions |
| Qube Research & Technologies Ltd | $72 783 206 | 343 398 | 0,57% | Actions |
| MACKENZIE FINANCIAL CORP | $70 641 875 | 333 295 | 0,55% | Actions |
| Advisors Capital Management, LLC | $69 429 626 | 327 575 | 0,54% | Actions |
| Swiss National Bank | $65 683 305 | 309 900 | 0,51% | Actions |
| Balyasny Asset Management L.P. | $58 364 883 | 275 371 | 0,45% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $56 877 630 | 268 354 | 0,44% | Actions |
| RHUMBLINE ADVISERS | $56 744 612 | 267 727 | 0,44% | Actions |
| BlackRock, Inc. | $55 976 419 | 264 102 | 0,44% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $54 809 634 | 258 597 | 0,43% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $53 654 295 | 253 146 | 0,42% | Actions |
| Quantinno Capital Management LP | $53 607 358 | 252 924 | 0,42% | Actions |
| RAYMOND JAMES FINANCIAL INC | $53 249 860 | 251 238 | 0,41% | Actions |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $52 211 551 | 246 339 | 0,41% | Actions |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $51 484 139 | 242 907 | 0,40% | Actions |
| Clark Capital Management Group, Inc. | $51 259 362 | 241 846 | 0,40% | Actions |
| Vanguard Global Advisers, LLC | $51 025 267 | 240 742 | 0,40% | Actions |
| Legal & General Group Plc | $50 185 731 | 236 781 | 0,39% | Actions |
| FIL Ltd | $49 419 958 | 233 168 | 0,38% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $49 341 000 | 232 797 | 0,38% | Actions |
| Eurizon Capital SGR S.p.A. | $47 173 414 | 222 564 | 0,37% | Actions |
| BARCLAYS PLC | $45 003 978 | 212 333 | 0,35% | Actions |
| PFA Pension, Forsikringsaktieselskab | $43 579 660 | 205 613 | 0,34% | Actions |
| Integral Health Asset Management, LLC | $42 390 000 | 200 000 | 0,33% | Actions |
| California Public Employees Retirement System | $41 574 204 | 196 151 | 0,32% | Actions |
| CONNING INC. | $39 578 271 | 186 734 | 0,31% | Actions |
| SEB Asset Management AB | $38 766 863 | 182 906 | 0,30% | Actions |
| BANK OF MONTREAL /CAN/ | $38 512 587 | 181 706 | 0,30% | Actions |
| GOLDMAN SACHS GROUP INC | $38 322 295 | 180 808 | 0,30% | Actions |
| Boston Partners | $35 509 632 | 167 514 | 0,28% | Actions |
| Focus Partners Wealth | $34 616 947 | 163 327 | 0,27% | Actions |
| STOREBRAND ASSET MANAGEMENT AS | $34 117 592 | 160 970 | 0,27% | Actions |
| COOKSON PEIRCE & CO INC | $32 977 089 | 155 589 | 0,26% | Actions |
| UBS Group AG | $32 934 699 | 155 389 | 0,26% | Actions |
| BRAUN STACEY ASSOCIATES INC | $32 724 232 | 154 396 | 0,25% | Actions |
| Willis Investment Counsel | $32 110 425 | 151 500 | 0,25% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $31 795 403 | 162 238 | 0,25% | Actions |
| LPL Financial LLC | $30 325 576 | 143 079 | 0,24% | Actions |
| APG Asset Management N.V. | $27 869 580 | 150 334 | 0,22% | Actions |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $26 893 912 | 126 888 | 0,21% | Actions |
| &PARTNERS | $26 382 365 | 124 363 | 0,21% | Actions |
| JANE STREET GROUP, LLC | $25 942 680 | 122 400 | 0,20% | Option d'achat |
| BANK OF AMERICA CORP /DE/ | $25 492 499 | 120 276 | 0,20% | Actions |
| Candriam S.C.A. | $25 459 925 | 120 238 | 0,20% | Actions |
| Squarepoint Ops LLC | $24 974 280 | 117 831 | 0,19% | Actions |
| Gotham Asset Management, LLC | $24 911 119 | 117 533 | 0,19% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $24 607 896 | 116 373 | 0,19% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24 569 456 | 115 921 | 0,19% | Actions |
| Robeco Institutional Asset Management B.V. | $23 854 123 | 112 546 | 0,19% | Actions |
| AEGON ASSET MANAGEMENT UK Plc | $22 866 862 | 107 888 | 0,18% | Actions |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $22 670 926 | 106 964 | 0,18% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22 530 921 | 106 303 | 0,18% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $22 106 507 | 104 301 | 0,17% | Actions |
| Moran Wealth Management, LLC | $22 053 609 | 104 051 | 0,17% | Actions |
| ABN AMRO Bank N.V. | $21 523 733 | 101 667 | 0,17% | Actions |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $21 496 202 | 123 876 | 0,17% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21 322 170 | 100 600 | 0,17% | Option d'achat |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21 146 252 | 99 770 | 0,16% | Actions |
| AVIVA PLC | $20 378 569 | 96 148 | 0,16% | Actions |
| SCHWARTZ INVESTMENT COUNSEL INC | $20 326 005 | 95 900 | 0,16% | Actions |
| Boston Common Asset Management, LLC | $20 282 767 | 95 696 | 0,16% | Actions |
| CAPTRUST FINANCIAL ADVISORS | $20 146 790 | 95 054 | 0,16% | Actions |
| Midwest Trust Co | $20 113 207 | 94 896 | 0,16% | Actions |
| LAZARD ASSET MANAGEMENT LLC | $20 035 210 | 94 528 | 0,16% | Actions |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $19 842 759 | 93 620 | 0,15% | Actions |
| BLAIR WILLIAM & CO/IL | $19 773 115 | 93 291 | 0,15% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $19 613 005 | 92 536 | 0,15% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19 160 280 | 90 400 | 0,15% | Option de vente |
| CITADEL ADVISORS LLC | $18 821 160 | 88 800 | 0,15% | Option d'achat |
| WELLINGTON MANAGEMENT GROUP LLP | $17 507 282 | 82 601 | 0,14% | Actions |
| Foundry Partners, LLC | $17 338 432 | 102 473 | 0,13% | Actions |
| MARSHALL WACE, LLP | $17 187 874 | 81 094 | 0,13% | Actions |
| Coho Partners, Ltd. | $16 981 317 | 89 103 | 0,13% | Actions |
| Copeland Capital Management, LLC | $16 902 800 | 79 749 | 0,13% | Actions |
| CIBC Asset Management Inc | $16 674 318 | 78 671 | 0,13% | Actions |
| Mitsubishi UFJ Trust & Banking Corp | $16 558 594 | 78 125 | 0,13% | Actions |
Initiés de la société 53 initiés · 26 dirigeants · 26 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| E. J. Davis | CEO and President | 1 juin 2026 S | 132 423 | 0 | 5 | $-14 656 302 |
| Surya N Mohapatra | Chairman, President & CEO | 30 avril 2012 F | 243 713 | 0 | 0 | $0 |
| Sam Samad | Executive Vice President & CFO | 22 juillet 2026 A | 33 478 | 0 | 0 | $0 |
| Mark Guinan | Executive Vice President & CFO | 7 mars 2022 F | 98 981 | 0 | 0 | $0 |
| Robert Hagemann | SVP & Chief Financial Officer | 5 mars 2013 F | 126 722 | 0 | 0 | $0 |
| Mark E Delaney | SVP & Chief Commercial Officer | 28 juillet 2026 S | 10 335 | 0 | 1 | $-376 288 |
| Karthik Kuppusamy | SVP, Clinical Solutions | 22 juillet 2026 L | 13 557 | 0 | 2 | $-2 167 772 |
| Patrick Plewman | SVP for Diagnostic Services | 22 juillet 2026 L | 15 293 | 0 | 5 | $-2 390 549 |
| Catherine T. Doherty | EVP, Regional Businesses | 5 mars 2026 S | 67 122 | 0 | 7 | $-6 671 228 |
| Michael E Prevoznik | SVP & General Counsel | 5 mars 2026 S | 37 557 | 0 | 7 | $-6 505 199 |
| Michael J Deppe | SVP, Corp. Controller & CAO | 4 mars 2026 F | 35 196 | 0 | 0 | $0 |
| Mark A Gardner | SVP of Molecular Gen & Oncol | 24 septembre 2024 F | 4 673 | 0 | 0 | $0 |
| Manner Carrie Eglinton | SVP, Advanced Diagnostics | 7 mars 2022 F | 48 391 | 0 | 0 | $0 |
| Manuel O. Mendez | SVP & Chief Commercial Officer | 17 février 2021 A | 29 045 | 0 | 0 | $0 |
| Robert A Klug | VP, Corporate Controller | 1 mars 2019 F | 6 261 | 0 | 0 | $0 |
| Jon R Cohen | SVP & Group Exec. Diag. Sol. | 8 mars 2018 M | 31 757 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Commercial | 1 mars 2018 G | 37 760 | 0 | 0 | $0 |
| Thomas F Bongiorno | VP and Corporate Controller | 2 mars 2015 F | 11 837 | 0 | 0 | $0 |
| John B. Haydon | SVP, Operations | 13 février 2014 A | 19 890 | 0 | 0 | $0 |
| Kathy Ordonez | SVP, Diagnostic Solutions | 31 mars 2013 F | 9 569 | 0 | 0 | $0 |
| Joan Elizabeth Miller | SVP-Oncology & Neurology Srvcs | 29 février 2012 F | 89 232 | 0 | 0 | $0 |
| Wayne R. Simmons | Vice President, Operations | 16 juin 2011 M | 47 150 | 0 | 0 | $0 |
| Robert E Peters | VP, Sales & Marketing | 12 février 2007 A | 12 974 | 0 | 0 | $0 |
| David M Zewe | SVP, Diagnostic Testing Ops | 12 février 2007 A | 31 079 | 0 | 0 | $0 |
| GRANT THOMAS W II | Sr VP, Ins. & Employer Serv. | 12 février 2007 A | — | 0 | 0 | $0 |
| Gerald C Marrone | SVP, Administration | 28 février 2004 F | 49 609 | 0 | 0 | $0 |
| Wright Lassiter III | Administrateur | 22 juillet 2026 L | 10 323 | 0 | 0 | $0 |
| Vicky B Gregg | Administrateur | 22 juillet 2026 A | 18 386 | 0 | 1 | $-239 700 |
| Robert B Carter | Administrateur | 22 juillet 2026 L | 3 864 | 0 | 0 | $0 |
| Timothy L Main | Administrateur | 22 juillet 2026 L | 22 460 | 0 | 0 | $0 |
| Timothy C Wentworth | Administrateur | 1 juillet 2026 A | 1 358 | 0 | 0 | $0 |
| Timothy M Ring | Administrateur | 20 mai 2026 A | 31 140 | 0 | 0 | $0 |
| Gary M Pfeiffer | Administrateur | 20 mai 2026 A | 31 005 | 0 | 1 | $-270 317 |
| Luis Diaz | Administrateur | 15 mai 2025 A | 4 054 | 0 | 0 | $0 |
| Tracey Doi | Administrateur | 15 mai 2025 A | 6 490 | 0 | 0 | $0 |
| Gail R Wilensky | Administrateur | 17 mai 2023 A | 20 506 | 0 | 0 | $0 |
| Stephen H Rusckowski | Administrateur | 6 mars 2023 F | 389 597 | 0 | 0 | $0 |
| Helen Torley | Administrateur | 25 mai 2021 A | 6 260 | 0 | 0 | $0 |
| Daniel Stanzione | Administrateur | 23 novembre 2020 S | 28 349 | 0 | 0 | $0 |
| Jenne K Britell | Administrateur | 4 juin 2018 G | 14 479 | 0 | 0 | $0 |
| Jeffrey M Leiden | Administrateur | 29 mai 2018 S | 6 000 | 0 | 0 | $0 |
| John B Ziegler | Administrateur | 22 février 2017 S | 16 557 | 0 | 0 | $0 |
| John C Baldwin MD | Administrateur | 12 août 2015 S | 12 949 | 0 | 0 | $0 |
| William F Buehler | Administrateur | 12 février 2014 M | 26 225 | 0 | 0 | $0 |
| GSK plc | Administrateur | 31 janvier 2011 S | 0 | 0 | 0 | $0 |
| Rosanne Haggerty | Administrateur | 6 mai 2010 A | 9 334 | 0 | 0 | $0 |
| William R Grant | Administrateur | 1 avril 2007 A | 3 334 | 0 | 0 | $0 |
| James F Flaherty III | Administrateur | 4 mai 2006 A | 1 667 | 0 | 0 | $0 |
| Kenneth D Brody | Administrateur | 28 avril 2004 S | 0 | 0 | 0 | $0 |
| Mary A Cirillo | Administrateur | 1 avril 2004 A | 2 627 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 13 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | 18 mai 2011 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Personne déclarante non divulguée | 1 février 2011 | — | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée | 20 mars 2009 | — | Dépôt initial | — | SEC |
| GlaxoSmithKline plc ×2 dépôts | 18 septembre 2008 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 16 février 2007 | — | Dépôt initial | — | SEC |
| Quest Diagnostics Incorporated - (FEIN No. ×2 dépôts | 19 janvier 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 15 décembre 2004 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 29 juin 2004 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 24 juin 2002 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Personne déclarante non divulguée | 22 mai 2002 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 12 avril 2002 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| IRS Identification Nos. of Above Persons (entities only) Quest Diagnostics Ventures LLC - (FEIN No., Quest Diagnostics Incorporated - (FEIN No. ×3 dépôts | 1 novembre 2001 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Personne déclarante non divulguée | 14 mai 2001 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 194 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IHF · iShares Trust | 3,93% | 199 039 SH | 21 août 2026 | Quotidien |
| FTDS · First Trust Exchange-Traded Fund | 2,17% | 3 760 NS | 30 juin 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,71% | 58 159 SH | 21 août 2026 | Quotidien |
| GK · AdvisorShares Trust | 1,43% | 2 156 NS | 30 juin 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,29% | 57 932 NS | 30 avril 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1,24% | 9 488 SH | 21 août 2026 | Quotidien |
| TMFX · RBB Fund, Inc. | 1,05% | 1 724 NS | 31 mai 2026 | N-PORT |
| ANEW · ProShares Trust | 0,92% | 364 NS | 31 mai 2026 | N-PORT |
| QLTY · GMO ETF Trust | 0,85% | 196 208 NS | 31 mai 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 0,82% | 4 047 NS | 30 avril 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,80% | 635 NS | 30 avril 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,78% | 4 426 SH | 21 août 2026 | Quotidien |
| QLV · FlexShares Trust | 0,74% | 6 461 NS | 30 avril 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0,72% | 741 NS | 31 mai 2026 | N-PORT |
| ESMV · iShares Trust | 0,72% | 236 SH | 21 août 2026 | Quotidien |
| PAPI · Morgan Stanley ETF Trust | 0,56% | 10 542 NS | 30 juin 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0,52% | 1 956 NS | 30 avril 2026 | N-PORT |
| PRAY · FIS Trust | 0,47% | 1 958 NS | 31 mai 2026 | N-PORT |
| ITAN · EA Series Trust | 0,46% | 2 110 NS | 29 mai 2026 | N-PORT |
| BTAL · AGF Investments Trust | 0,46% | 6 072 NS | 30 juin 2026 | N-PORT |
| KNGZ · First Trust Exchange-Traded Fund VI | 0,44% | 1 301 NS | 30 juin 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,44% | 1 055 NS | 30 avril 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0,44% | 409 814 NS | 30 avril 2026 | N-PORT |
| FVD · First Trust Exchange-Traded Fund | 0,43% | 161 912 NS | 30 juin 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,41% | 3 999 NS | 31 mai 2026 | N-PORT |
| IYH · iShares Trust | 0,41% | 65 931 SH | 21 août 2026 | Quotidien |
| VOE · VANGUARD INDEX FUNDS | 0,40% | 711 079 SH | 19 août 2026 | Quotidien |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 8 682 NS | 30 avril 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 8 368 NS | 30 avril 2026 | N-PORT |
| IMCV · iShares Trust | 0,37% | 18 030 SH | 21 août 2026 | Quotidien |
| SUSA · iShares Trust | 0,35% | 59 963 SH | 21 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,35% | 51 278 NS | 30 avril 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,34% | 23 030 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,34% | 330 273 SH | 19 août 2026 | Quotidien |
| IXJ · iShares Trust | 0,32% | 58 047 SH | 21 août 2026 | Quotidien |
| RXL · ProShares Trust | 0,31% | 1 147 NS | 31 mai 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,31% | 2 194 NS | 30 avril 2026 | N-PORT |
| GNOM · Global X Funds | 0,28% | 789 NS | 31 mai 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,26% | 79 983 NS | 30 avril 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,26% | 7 703 000 | 19 août 2026 | Quotidien |
| IWS · iShares Trust | 0,25% | 166 379 SH | 21 août 2026 | Quotidien |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,24% | 18 806 NS | 30 avril 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 8 995 NS | 30 avril 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0,23% | 3 340 NS | 30 avril 2026 | N-PORT |
| CVMC · Morgan Stanley ETF Trust | 0,23% | 1 137 NS | 30 juin 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 26 229 NS | 30 avril 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 4 242 SH | 21 août 2026 | Quotidien |
| DFVE · DoubleLine ETF Trust | 0,23% | 351 NS | 30 juin 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,23% | 2 398 948 SH | 19 août 2026 | Quotidien |
| EUSA · iShares, Inc. | 0,22% | 18 045 SH | 21 août 2026 | Quotidien |